Terms: = Gastric cancer AND HEY1, CHF-2, 23462, ENSG00000164683, HESR1, CHF2, HESR-1, MGC1274, HRT-1, OAF1, HERP2 AND Treatment
5 results:
1. Acquisition of paclitaxel resistance modulates the biological traits of gastric cancer AGS cells and facilitates epithelial to mesenchymal transition and angiogenesis.
Niapour A; Seyedasli N
Naunyn Schmiedebergs Arch Pharmacol; 2022 May; 395(5):515-533. PubMed ID: 35122114
[TBL] [Abstract] [Full Text] [Related]
2. Long noncoding RNA LINC00982 upregulates CTSF expression to inhibit gastric cancer progression via the transcription factor hey1.
Zheng L; Cao J; Liu L; Xu H; Chen L; Kang L; Gao L
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G816-G828. PubMed ID: 33236952
[TBL] [Abstract] [Full Text] [Related]
3. Tangeretin enhances radiosensitivity and inhibits the radiation-induced epithelial-mesenchymal transition of gastric cancer cells.
Zhang X; Zheng L; Sun Y; Wang T; Wang B
Oncol Rep; 2015 Jul; 34(1):302-10. PubMed ID: 25998143
[TBL] [Abstract] [Full Text] [Related]
4. Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6/STAT3/Jagged-1/Notch positive feedback loop.
Yang Z; Guo L; Liu D; Sun L; Chen H; Deng Q; Liu Y; Yu M; Ma Y; Guo N; Shi M
Oncotarget; 2015 Mar; 6(7):5072-87. PubMed ID: 25669984
[TBL] [Abstract] [Full Text] [Related]
5. Atractylenolide I-mediated Notch pathway inhibition attenuates gastric cancer stem cell traits.
Ma L; Mao R; Shen K; Zheng Y; Li Y; Liu J; Ni L
Biochem Biophys Res Commun; 2014 Jul; 450(1):353-9. PubMed ID: 24944018
[TBL] [Abstract] [Full Text] [Related]
